company

BIOGEN NORWAY AS

0485 OSLO

Return on Equity
4,55 %
Current Ratio
5,7
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue284 385 000
Net Income7 450 000
Total Assets198 402 000
Total Equity163 662 000
Income (NOK)2022
Revenue284 385 000
Expenditure274 590 000
Operating Profit9 795 000
Financial Income1 000
Financial Costs232 000
Financial Balance−231 000
Earnings Before Tax9 564 000
Tax2 114 000
Net Income7 450 000
Balance (NOK)2022
Total Fixed Assets260 000
Total Current Assets198 142 000
Total Assets198 402 000
Total Retained Equity163 562 000
Total Equity163 662 000
Total Long-Term Debt0
Total Current Debt34 740 000
Total Equity and Debt198 402 000
Cash flow (NOK)2022
Sales Income284 385 000
Other Income0
Revenue284 385 000
Cost of Goods Sold226 841 000
Salary Costs32 438 000
Depreciation88 000
Impairment0
Expenditure274 590 000
Operating Profit9 795 000
Financial Income1 000
Financial Costs232 000
Financial Balance−231 000
Dividends0
Net Income7 450 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets103 000
Real Eastate0
Machinery and Plant Facilities157 000
Fixtures0
Total Tangible Assets157 000
Total Fiancial Fixed Assets0
Total Fixed Assets260 000
Stock0
Total Investments0
Cash, Bank146 264 000
Total Current Assets198 142 000
Total Assets198 402 000
Total Equity163 662 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors1 047 000
Unpaid Taxes10 910 000
Dividends0
Other Current Debt20 689 000
Total Current Debt34 740 000
Total Equity and Debt198 402 000
Financial indicators2022
Return on Equity4,55 %
Debt-to-Equity Ratio0
Operating Profit Margin3,44 %
Current Ratio5,7
Quick Ratio5,7
Equity Ratio0,82
Gross Profit Margin20,23 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English